Year of publication | Number (percent) | Study population | Number (percent) |
2000-2006 | 5 (10) | People with CD | 19 (38) |
2007-2012 | 21 (41) | People with FI | 1 (2) |
2013-2015 | 24 (47) | General or mixed | 31 (62) |
Study design | Chronic disease | ||
Cross-sectional | 42 (82) | Diabetes | 39 (76) |
Longitudinal | 3 (6) | Hypertension | 12 (24) |
Case-control | 6 (12) | Dyslipidemia | 10 (20) |
Asthma | 5 (10) | ||
Study setting | Cardiovascular disease | 4 (8) | |
USA | 32 (63) | Metabolic syndrome | 2 (4) |
Canada | 8 (16) | Kidney disease | 1 (2) |
Malaysia | 3 (5) | ||
Iran | 2 (4) | FI Measurement | |
Mexico | 1 (2) | HFSSM | 39 (76) |
Brazil | 1 (2) | Other | 12 (24) |
Jordan | 1 (2) | ||
Kenya | 1 (2) | Main finding | |
Puerto Rico | 1 (2) | Positive association-FI & CD | 42 (82) |
Australia | 1 (2) | No positive association | 9 (18) |